✦ LIBER ✦

Initial chemotherapy for stage II testicular non-seminoma

✍ Scribed by A. Horwich; S. Stenning

Book ID: 104657959
Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 329 KB
Volume: 12
Category: Article
ISSN: 0724-4983
DOI: 10.1007/bf00192276

No coin nor oath required. For personal study only.

✦ Synopsis

We assessed the alternative approach to stage II testicular non-seminoma, namely to treat patients following orchidectomy with platinum-based combination chemotherapy. Limited lymphadenectomy is undertaken only for patients with residual abnormal lymph-node masses following chemotherapy. This is a standard approach for patients with more advanced presentations of metastatic non-seminoma, and prognostic factor analysis suggests that chemotherapy is associated with better results in limited-volume stage II disease [8,9].

📜 SIMILAR VOLUMES

Radiation therapy for stage I and II tes

Radiation therapy for stage I and II testicular seminoma

✍ Jeffrey P. Long; Hamed H. Tewfik 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Treatment-related ureteral cancer follow

✍ Kosuke Mizutani; Hidetoshi Ehara; Shigeaki Yokoi; Nguyen B Phuoc; Takashi Deguch 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 248 KB

Surgery versus surveillance in stage I n

Surgery versus surveillance in stage I non-seminoma testicular cancer

✍ Dirk J.A. Sonneveld; Heimen Schraffordt Koops; Dirk Th Sleijfer; Harald J. Hoeks 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Today, the standard treatment for patients with clinical Stage I non-seminomatous testicular germ cell tumors (NSTGCT) following orchidectomy is either primary retroperitoneal lymph node dissection (RPLND) or close surveillance with cisplatin-based polychemotherapy in case of a relapse. Both treatme

Testicular seminoma: Histological findin

Testicular seminoma: Histological findings and their prognostic significance for stage II disease

✍ Dr. Jan Folkvard Evensen; Sophie Dorothea Fosså; Kjell Kjellevold; Hans Henrik L 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

Risk factors for testicular cancer – dif

Risk factors for testicular cancer – differences between pure non-seminoma and mixed seminoma/non-seminoma?

✍ E. L. Aschim; T. B. Haugen; S. Tretli; A. K. Daltveit; T. Grotmol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Is mediastinal irradiation necessary for

Is mediastinal irradiation necessary for stage I testicular seminoma?

✍ Baby Jose; Lee P. Perkins; Howard Kays; Ann M. Chu; Subhash C. Sharma 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

This study is a review of 39 patients with testicular seminoma, Stage I, treated at the Department of Radiation Oncology, James Graham Brown Cancer Center from 1959 to 1978. The age of the patients ranged from 16 to 70 years with a median of 37. Thirty-two (82%) patients presented with swelling or m